Quest Diagnostics stated that MCaST, on which the blood test is based, is a “cohesive risk model” developed by Dr. Samir Hanash’s laboratory at MD Anderson Cancer Center.

Quest will develop a blood test to detect one or more cancers, including colorectal, lung, breast, pancreatic, ovarian, liver, prostate, esophageal and stomach, based on MD Anderson technology.

Cornell/Lake Holcombe juniors Brooke Anderson and Grace Harycki have been selected to the All-East Lakeland Conference softball first team.

Texas News MD Anderson, Texas Children’s approve pediatric cancer partnership UT Systems regents voted to approve the partnership Wednesday afternoon.

Local News ExxonMobil gifts major donation to MD Anderson to launch Be Well Beaumont initiative The $10 million donation from ExxonMobil will help launch the initiative, Be Well Beaumont.

Single-molecule localization microscopy (SMLM) is a powerful tool for observing structures beyond the diffraction limit of light. Combining SMLM with engineered point spread functions (PSFs) enables ...

Red Lobster had almost 600 total restaurants and closed roughly 50 shortly before filing bankruptcy. The company's bankruptcy plan closes dozens more.

RUSH MD Anderson will create a more comprehensive cancer program through integrated services consistently available across its medical centers and regional locations. RUSH MD Anderson patients will be ...

A prominent MD Anderson Cancer Center scientist pushed back on a lawsuit that claims she tried to take credit for a junior faculty member’s research, saying a third-party review determined she ...

Abstract. Transcriptionally active fusions of ESR1 (ESR1-TAF) and somatic mutations in the estrogen receptor alpha (ERα) ligand-binding domain (LBD) cause endocrine therapy resistance in breast cancer ...

MD Anderson and Panacea Venture announced the launch of Manaolana Oncology, a new company created to develop and advance antibody-based therapies against novel cancer targets.